×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Fairman Jeff

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchOct 26, 2022Sale$40.0010,000400,000286,227Oct 28, 2022, 06:56 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchOct 11, 2022Sale$25.505,000127,500296,227Oct 13, 2022, 04:57 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchSep 02, 2022Option Exercise$26.3851913,69117,143Sep 07, 2022, 04:37 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchSep 06, 2022Sale$26.585,000132,892301,563Sep 07, 2022, 04:37 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchAug 04, 2022Sale$25.5010,000255,000311,227Aug 05, 2022, 07:12 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchAug 05, 2022Sale$25.705,000128,507306,227Aug 05, 2022, 07:12 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchMay 20, 2022Sale$25.504,112104,856321,227May 24, 2022, 04:32 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchMay 05, 2022Sale$25.8088822,914325,339May 09, 2022, 04:35 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchApr 05, 2022Sale$25.595,000127,950326,227Apr 07, 2022, 05:24 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchMar 11, 2022Sale$25.5010,000255,000331,227Mar 15, 2022, 09:09 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchDec 20, 2021Option Exercise$1.794,4698,00010,629Feb 08, 2022, 05:27 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchDec 27, 2021Option Exercise$1.794,7508,50210,910Dec 28, 2021, 04:15 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchDec 27, 2021Sale$23.604,750112,0926,335Dec 28, 2021, 04:15 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchDec 16, 2021Option Exercise$1.794,6198,26810,779Dec 20, 2021, 04:35 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchDec 16, 2021Sale$22.504,619103,9286,160Dec 20, 2021, 04:35 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchDec 09, 2021Option Exercise$1.791312346,291Dec 13, 2021, 05:20 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchDec 09, 2021Sale$22.501312,9486,160Dec 13, 2021, 05:20 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchOct 26, 2021Sale$22.694,750107,7785,144Oct 28, 2021, 06:00 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchOct 26, 2021Option Exercise$1.794,7508,5029,894Oct 28, 2021, 06:00 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchSep 27, 2021Option Exercise$1.794,7508,5029,894Sep 29, 2021, 07:52 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchSep 27, 2021Sale$26.174,750124,3035,283Sep 29, 2021, 07:52 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchAug 26, 2021Option Exercise$1.794,7508,5029,894Aug 30, 2021, 06:06 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchAug 26, 2021Sale$25.384,750120,5438,362Aug 30, 2021, 06:06 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchJul 26, 2021Sale$22.704,750107,8255,144Jul 28, 2021, 04:32 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchJul 26, 2021Option Exercise$1.794,7508,5029,894Jul 28, 2021, 04:32 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchJun 28, 2021Option Exercise$1.794,7508,5029,894Jun 30, 2021, 05:41 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchJun 28, 2021Sale$24.374,750115,7705,280Jun 30, 2021, 05:41 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchApr 22, 2021Option Exercise$1.792,7934,9994,201Apr 23, 2021, 07:31 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchMar 26, 2021Sale$23.884,750113,4332,769Mar 29, 2021, 07:18 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchMar 26, 2021Option Exercise$0.044,7501906,158Mar 29, 2021, 07:18 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchFeb 26, 2021Option Exercise$0.044,7501906,158Mar 02, 2021, 12:00 AM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchFeb 26, 2021Sale$23.934,750113,6632,848Mar 02, 2021, 12:00 AM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchJan 26, 2021Option Exercise$0.044,7501906,158Jan 28, 2021, 04:36 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchJan 26, 2021Sale$25.274,750120,0151,833Jan 28, 2021, 04:36 PM
PCVXVaxcyte, Inc.Fairman JeffVP, ResearchDec 29, 2020Option Exercise$1.797401,3251,408Dec 30, 2020, 08:26 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe